Skip to content

Terrie Curran, Director at Arcutis Biotherapeutics, sold ARQT on Aug 27, 2026

Data as of Oct 16

▼ SELL$677K27,052 shares at $25.03Terrie Curran DirectorARQT Arcutis Biotherapeutics, Inc.
Watch ARQT
Traded
Aug 27, 2026
Disclosed
Aug 28, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Terrie Curran, Director at Arcutis Biotherapeutics, sold ARQT on Aug 27, 2026TRADEDDISCLOSED
ARQTSimilar stocks (XLV — its sector index fund), rebased to ARQT's price on the disclosure day
ARQT since disclosure
+21.2%
after the sale
Similar stocks (XLV) since disclosure
+3.2%
XLV — its sector index fund

Change in closing price from Aug 28, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLTerrie Curran DirectorARQT Arcutis Biotherapeutics, Inc.$279Kdisclosed Aug 28 · filed 1 day after the trade

See every trade on ARQT →